Close

Analyst Ratings for Century Therapeutics (IPSC) [Neutrals]

IPSC Rating Summary

IPSC Price Target Summary

* Over Last 12-Mos
  |   Expand Research on IPSC
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $13.60 (+351.8%) * Over Last 12-Mos
Rating Score: 7.8 / 10   Percentile Rank: 82%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/28/2023 JPMorgan Eric Joseph Downgrade Neutral
(Overweight)
5.00
(28.00)
2.40
(3.01)
25.42% Details
5/12/2022 William Blair Sami Corwin New Coverage Market Perform
(N/A)
N/A
(N/A)
8.08
(3.01)
-62.75% Details